Medical disclaimer: Trimi Health publishes general educational information about GLP-1 weight-loss medications. This content is not medical advice. Treatment decisions must involve a licensed clinician who has reviewed the patient's full medical history. Patients should not start, stop, or change a prescription based on website content alone.
Compounded medication: Compounded semaglutide and compounded tirzepatide are prepared per individual prescription by a state-licensed 503A compounding pharmacy. Compounded medications are not FDA-approved. FDA does not review compounded drugs for safety, effectiveness or quality before marketing.
Risk acknowledgment: GLP-1 medications carry risks including nausea, diarrhea, vomiting, constipation, pancreatitis, gallbladder disease, kidney injury, and a boxed warning regarding thyroid C-cell tumors. Patients with a personal or family history of medullary thyroid carcinoma or MEN2 should not use these medications. Discuss your full health history with your prescribing clinician.
Results vary: Weight-loss outcomes referenced anywhere on this site reflect averages from published clinical trials. Individual results vary based on starting weight, dose, adherence, diet, exercise, and medical history. Trial averages are not guarantees of personal outcome.
State availability: Trimi operates in most US states. Each prescription is issued by a provider licensed in the patient's state of residence. State availability is verified during the online assessment before any payment is taken.
© 2026 Trimi · Established 2024 · All rights reserved.